Safety considerations for cereblon-recruiting targeted protein degraders
Aclairo’s Ron Wange and the HESI Targeted Protein Degrader Safety Group recently published a review of key safety issues with […]
Scientific Perspectives, Uncategorized
Uncategorized
Uncategorized
SOT 65th Annual Meeting
EPL and Aclairo Pharmaceutical Development Group, Inc. are looking forward to seeing everyone at the SOT 65th Annual Meeting in
Uncategorized
HESI Targeted Protein Degrader Safety Group
Aclairo’s Ron Wange and the HESI Targeted Protein Degrader Safety Group recently published a review of key safety issues with
Uncategorized
ASGCT 2026
Jennifer Wheeler, Uyen Dinh, PhD, and Lauren Mihalcik, PhD, DABT will all be in Boston next week for ASGCT. This